Atrium Therapeutics, Inc. (RNA)
NASDAQ·Healthcare·Biotechnology
$12.28
-1.21%
Mkt Cap $200.14M
No analyst coverage available
We don't have analyst ratings or price target data for Atrium Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.